Home SurgiMab

SurgiMab

In operation
-
Pharmaceutical Research and Development Company
Basic
Enterprise Profile

Basic Information

SurgiMab develops injectable fluorescent conjugates for tumor surgeons to clearly delineate tumors and visualize clinically sized nodules that are invisible to the naked eye during fluorescence-guided surgery (FGS).
SurgiMab S.A.S.
France
less than 15 people
January 01, 2011
--

Enterprise Profile

Industrial Sector
New Drug Development Clinical Tools
Concept
Tumor